Olaquindox

• Description :

  Olaquindox, a quinoxalin derivative, is an orally active antibiotic. Olaquindox stimulates growth and decreases intestinal mucosal immunity of piglets[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H334

• Target :

  Antibiotic; Bacterial

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/olaquindox.html

• Purity :

  99.88

• Solubility :

  DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles :

  O=C(C1=C(C)[N+]([O-])=C2C=CC=CC2=[N+]1[O-])NCCO

• Molecular Formula :

  C12H13N3O4

• Molecular Weight :

  263.25

• Precautions :

  H302, H334

• References & Citations :

  [1]Ding MX, et al. Olaquindox and cyadox stimulate growth and decrease intestinal mucosal immunityof piglets orally inoculated with Escherichia coli. J Anim Physiol Anim Nutr (Berl) . 2006 Jun;90 (5-6) :238-43.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [23696-28-8]